GEN reports Thursday, Feb 4, 2027, after the close. After the last 4 reports the stock moved +15.8%, +3.8%, +12.3%, +8.1% the next day.
EPS 0.74 against an estimate of 0.72 (+3.0% surprise). The stock moved +15.8% the next trading day.
GEN is expected to report on Thursday, Feb 4, 2027, after the close (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Oct 28, 2026 | 0.72 | 0.74 | +15.8% | — |
| Aug 6, 2026 | 0.69 | 0.71 | +3.8% | +5.2% |
| May 7, 2026 | 0.65 | 0.67 | +12.3% | +14.8% |
| Feb 5, 2026 | 0.63 | 0.64 | +8.1% | +5.0% |
| Nov 6, 2025 | 0.61 | 0.62 | +1.3% | +5.0% |
| Aug 7, 2025 | 0.60 | 0.64 | +7.7% | +11.5% |
| May 6, 2025 | 0.58 | 0.59 | +8.2% | +13.1% |
| Jan 30, 2025 | 0.55 | 0.56 | −3.5% | −0.6% |
Average move the next trading day over the last 8 reports: ±7.6% (7 of 8 up).
GEN is in an uptrend, momentum firm. $30 is the level overhead; $27.97 the first support below.
GEN at $29.71. Nearest resistance $30.00 (+1.0%). Nearest support $27.97 (−5.9%).
GEN chart, levels and analysis · Earnings this week
GEN is expected to report on Thursday, Feb 4, 2027, after the close.
GEN reports after the close, US Eastern time.
After its report on Oct 28, 2026, GEN moved +15.8% the next trading day.
Over the last 8 reports, GEN moved 7.6% on average the next trading day, up 7 times out of 8.